The remarkable recent advances in protein structure prediction have enabled computational modeling of protein structures with considerably higher accuracy than ever before. While state-of-the-art structure prediction methods provide self-assessment confidence scores of their own predictions, an independent and open-access system for protein scoring is still needed that can be applied to a broad range of predictive modeling scenarios. Here, we present iQDeep, an integrated and highly customizable web server for protein scoring, freely available at http://fusion.cs.vt.edu/iQDeep. The underlying method of iQDeep employs multiscale deep residual neural networks (ResNets) to perform residue-level error classifications, and then probabilistically combines the error classifications for protein scoring. By adjusting the error resolutions, our method can reliably estimate the standard- or high-accuracy variants of the Global Distance Test metric for versatile protein scoring. The performance of the method has been extensively tested and compared against the state-of-the-art approaches in multiple rounds of Critical Assessment of Techniques for Protein Structure Prediction (CASP) experiments including benchmark assessment in CASP12 and CASP13 as well as blind evaluation in CASP14. The iQDeep web server offers a number of convenient features, including (i) the choice of individual and batch processing modes; (ii) an interactive and privacy-preserving web interface for automated job submission, tracking, and results retrieval; (iii) web-based quantitative and visual analyses of the results including overall estimated score and its residue-wise breakdown along with agreements between various sequence- and structural-level features; (iv) extensive help information on job submission and results interpretation via web-based tutorial and help tooltips.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291203 | PMC |
http://dx.doi.org/10.1016/j.jmb.2023.168057 | DOI Listing |
JAMA Netw Open
January 2025
Division of Geriatrics, School of Medicine, University of California San Francisco.
Importance: The Walter Index is a widely used prognostic tool for assessing 12-month mortality risk among hospitalized older adults. Developed in the US in 2001, its accuracy in contemporary non-US contexts is unclear.
Objective: To evaluate the external validity of the Walter Index in predicting posthospitalization mortality risk in Brazilian older adult inpatients.
Blood
January 2025
IDIBAPS, Barcelona, Spain.
Previous studies have reported that chronic lymphocytic leukemia (CLL) shows a de novo chromatin activation pattern as compared to normal B cells. Here, we explored whether the level of chromatin activation is related to the clinical behavior of CLL. We identified that in some regulatory regions, increased de novo chromatin activation is linked to clinical progression whereas, in other regions, it is associated with an indolent course.
View Article and Find Full Text PDFMol Divers
January 2025
Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
The drug combination is an attractive approach for cancer treatment. PARP and kinase inhibitors have recently been explored against cancer cells, but their combination has not been investigated comprehensively. In this study, we used various drug combination databases to build ML models for drug combinations against brain cancer cells.
View Article and Find Full Text PDFMed Klin Intensivmed Notfmed
January 2025
Ankara Training and Research Hospital, Department of Emergency Medicine, University of Health Sciences, Ankara, Turkey.
Background: In this study, we aimed to evaluate the role of the glucose-to-potassium ratio in predicting in-hospital mortality and prognosis of patients diagnosed with sepsis and septic shock in an emergency department and admitted to an emergency critical intensive care unit (ICU).
Methods: This study was a retrospective and observational evaluation of nontraumatic sepsis and septic shock patients > 18 years of age who were admitted to the emergency department of a tertiary training and research hospital and had available glucose and potassium values at the time of admission. The patients were evaluated over a 24-month period.
Aim: This study aims to investigate the clinical utility of the derived neutrophil-to-lymphocyte ratio (dNLR) and the Geriatric Nutritional Risk Index (GNRI) in predicting treatment outcomes for patients with unresectable hepatocellular carcinoma (HCC) undergoing combination therapy with atezolizumab and bevacizumab (Atez/Bev).
Methods: A retrospective analysis was conducted on 310 patients. The dNLR, NLR, and GNRI were calculated, and their impact on progression-free survival (PFS) and overall survival (OS) was assessed.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!